Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COHERE: Continuous vs Intermittent Heparin in AF Ablation
NCT01935557Phase 3Completed
- Start
- Dec 2012
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heparin in Atrial fibrillation (AFib). Started Dec 2012; status: completed.
02
Drugs
heparin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01935557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935557.